Clinical Trial Update: Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Carilizumab with Albumin Paclitaxel as second-line therapy for advanced gastric cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Albumin Paclitaxel (nab-paclitaxel)
• Carilizumab (Carilizumab)

Snippet

Sponsor: Shandong Tumor Hospital | Conditions: Gastric Cancer, Second-line Therapy | Phase 2 | Status: RECRUITING